SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Schmid Timothy (Last) (First) (Middle) ONE JOHNSON & JOHNSON PLAZA (Street) NEW BRUNSWICK NJ 08933 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 10/23/2023	3. Issuer Name and Ticker or Trading Symbol JOHNSON & JOHNSON [ JNJ ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) EVP, WW Chair, MedTech	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	8,979	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Options (Right to Buy)	02/09/2019	02/08/2026	Common Stock	15,571	$101.87	D
Employee Stock Options (Right to Buy)	02/13/2020	02/13/2027	Common Stock	13,625	$115.67	D
Employee Stock Options (Right to Buy)	02/12/2021	02/11/2028	Common Stock	8,998	$129.51	D
Employee Stock Options (Right to Buy)	02/11/2022	02/11/2029	Common Stock	11,070	$131.94	D
Employee Stock Options (Right to Buy)	02/10/2023	02/10/2030	Common Stock	22,527	$151.41	D
Employee Stock Options (Right to Buy)	(1)	02/13/2033	Common Stock	12,388	$162.75	D
Employee Stock Options (Right to Buy)	02/08/2024	02/08/2031	Common Stock	21,574	$164.62	D
Employee Stock Options (Right to Buy)	02/14/2025	02/14/2032	Common Stock	17,431	$165.89	D
Restricted Share Units	(2)	(2)	Common Stock	1,497	(2)	D
Restricted Share Units	02/08/2024	02/08/2024	Common Stock	1,964	(3)	D
Restricted Share Units	02/14/2025	02/14/2025	Common Stock	1,765	(3)	D

Explanation of Responses:

1. The Stock Option Award was granted on February 13, 2023 and vests in three equal annual installments beginning on the first anniversary of the grant date.

2. The Restricted Share Units were granted on February 13, 2023 and vest in three annual equal installments beginning on the first anniversary of the grant date.

3. Each Restricted Share Unit represents a contingent right to acquire one share of Company Common Stock.

Remarks:

schmidpoa1.txt

	Raavi Deol, as attorney-in-fact, for Timothy Schmid	11/02/2023
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.